Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Danish Medical Bulletin
|
July 2, 2010
Incretin hormones and beta cell function in chronic pancreatitis
Filip Krag Knop
Ugeskrift for Laeger
|
June 8, 2007
[Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus]
Tina Vilsbøll, Filip Krag Knop
Ugeskrift for Laeger
|
June 8, 2007
[GLP-1-based treatment of type 2 diabetes mellitus]
Filip Krag Knop, Tina Vilsbøll
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 13, 2023
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes
Nicklas Järvelä Johansen, Filip Krag Knop
BMC Medicine
|
November 24, 2023
Why diversity among participants in clinical studies is not always preferable: the case for small, exploratory studies
Anne-Marie Ellegaard, Filip Krag Knop
Endocrinology, Diabetes & Metabolism
|
February 19, 2022
MYC mRNA expression throughout the intestine is not associated with body mass index or type 2 diabetes
Anne-Marie Ellegaard, Filip Krag Knop
Ugeskrift for Laeger
|
February 28, 2006
[The benefits of diagnostic imaging in general practice]
Filip Krag Knop, Jens Aage Stauning
Drugs
|
May 8, 2021
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
Andreas Andersen, Filip Krag Knop, Tina Vilsbøll
JCEM Case Reports
|
November 1, 2023
Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea
Martin Lund Kårhus, Elisabeth Knudsen, Filip Krag Knop
Ugeskrift for Laeger
|
December 21, 2017
[The dilemma of Danish Christmas lunches]
Amalie Rasmussen Lanng, Lærke Smidt Gasbjerg, Filip Krag Knop
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Danish Medical Bulletin
|
July 2, 2010
Incretin hormones and beta cell function in chronic pancreatitis
Filip Krag Knop
Ugeskrift for Laeger
|
June 8, 2007
[Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus]
Tina Vilsbøll, Filip Krag Knop
Ugeskrift for Laeger
|
June 8, 2007
[GLP-1-based treatment of type 2 diabetes mellitus]
Filip Krag Knop, Tina Vilsbøll
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 13, 2023
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes
Nicklas Järvelä Johansen, Filip Krag Knop
BMC Medicine
|
November 24, 2023
Why diversity among participants in clinical studies is not always preferable: the case for small, exploratory studies
Anne-Marie Ellegaard, Filip Krag Knop
Endocrinology, Diabetes & Metabolism
|
February 19, 2022
MYC mRNA expression throughout the intestine is not associated with body mass index or type 2 diabetes
Anne-Marie Ellegaard, Filip Krag Knop
Ugeskrift for Laeger
|
February 28, 2006
[The benefits of diagnostic imaging in general practice]
Filip Krag Knop, Jens Aage Stauning
Drugs
|
May 8, 2021
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
Andreas Andersen, Filip Krag Knop, Tina Vilsbøll
JCEM Case Reports
|
November 1, 2023
Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea
Martin Lund Kårhus, Elisabeth Knudsen, Filip Krag Knop
Ugeskrift for Laeger
|
December 21, 2017
[The dilemma of Danish Christmas lunches]
Amalie Rasmussen Lanng, Lærke Smidt Gasbjerg, Filip Krag Knop
Page
of 11